Question 1

How many shares of BMRN does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 20.4M shares of BMRN (BIOMARIN PHARMACEUTICAL INC).

Question 2

What is BlackRock, Inc.'s BMRN position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s BMRN position is worth $1.2B.

Question 3

Is BlackRock, Inc. buying or selling BMRN?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their BMRN position (+3.2% change in shares).

Question 4

When did BlackRock, Inc. first buy BMRN?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in BMRN in 2024-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	20.4M	+3.2%	$1.2B	0.0%	$57.22	33
2026-Q1	Increased	19.8M	+3.6%	$1.1B	0.0%	$56.49	33
2025-Q4	Decreased	19.1M	-13.2%	$1.1B	0.0%	$59.43	0
2025-Q3	Decreased	22M	-8.2%	$1.2B	0.0%	$54.16	0
2025-Q2	Increased	24M	+0.9%	$1.3B	0.0%	$54.97	32
2025-Q1	Increased	23.8M	+1.1%	$1.7B	0.0%	$70.69	32
2024-Q4	Increased	23.5M	+3.9%	$1.5B	0.0%	$65.73	33
2024-Q3	First report	22.6M	-	$1.6B	0.0%	$70.29	0

BMRN8 quarters

BMRN
8 quarters